The proposed treatment developed by Kalight has acquired full patent approval for its 47 claims in both the United States and Russia. The treatment approach also has been filed in the Euopean Office, Japan, China and Norway and is moving toward approval in those countries. Howard Zik, the founder, has known the disease personally within his family and that experience originally served as the impetus to fully commit himself and his company to finding a novel effective treatment. Kalight's objective includes promoting recovery from the disease and elimination of permanent damage that is too often inflicted by Bell's and similar diseases. The proposed treatment, moreover, is phase 2 ready insofar as its safety has been confirmed through successful phase 1 studies involved in treating hypertension.
Kalight is seeking to license out its technology to qualified company(ies) that share its values of innovative research and human concerns. It is seeking an international commitment, but is willing to consider licensing partnerships that apply to specific countries.
The proposed treatment is based upon a novel causal dynamic for Bell's and similar herpes diseases. This dynamic involves arterial constriction that is activated through specific enzyme responses and mechanisms that act upon the calcium channels. The treatment consists of the use of selected calcium channel blockers subject to Kalight's patent (US #6,191,151), used either independently or in combination with certain identified antivirals. The treatment is designed to halt and reverse the pathological process. The wide range of its approved 47 claims allow any future accepted licensee various options regarding which calcium channel blocker it selects to develop and market. Each compound has its own unique strengths/advantages. The phase 2 study, moreover, should be of short duration due to the availablity of specific technologies to evaluate effectiveness early.
Companies interested in such licensing may contact Kalight at howardzik@kalight.com. Together we may build a more promising future.
